GGrantIndex
← Leaderboards

Zhexing Wen

University Of Maryland Baltimore

Google Scholar ↗PubMed ↗ORCID ↗
$10,696,621
Attributed
$24,673,954
Total exposure
14
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $5.3M · FY2016–25
$10M$7.5M$5M$2.5M$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$24,673,954 · 14

By mechanism

R01$17,679,221 · 7
RF1$4,119,330 · 1
R21$1,715,845 · 4
U19$934,723 · 1
R43$224,835 · 1

Top collaborators

Most similar at University Of Maryland Baltimore

Same institution · by research overlap

Others in their field

Top investigators on “Alzheimer&Apos”

Research focus

Alzheimer&AposNeuronsInduced Pluripotent Stem CellBrainCellsGeneticCell TypePathway InteractionsPathogenesisNeurodegenerative DisordersAffectCell LineAstrocytesSynapsesMolecularReportingPathologicInnovationLinkPlayPharmaceutical PreparationsS DiseaseBaseBiological

Grant awards (39)

Understanding the functional impacts of Aβ variants in Alzheimer's disease with human brain organoids$1,785,477
RF1 · FY2025 · AG · contact PI
Genetics-informed dissection of human brain cell-cell communication in Alzheimer's disease progression$773,979
R01 · FY2025 · AG
Drug repositioning for Alzheimer's disease via genetics, electronic health records, and human iPSC models$762,918
R01 · FY2025 · AG
Investigation of active kinome networks in Alzheimer's dementia.$741,787
R01 · FY2025 · AG
Leveraging human iPSC technology to understand the role of neuroinflammation in 22q11.2 deletion syndrome$610,784
R01 · FY2025 · MH · contact PI
Leveraging iPSC technology to understand neuro-immune responses to SARS-CoV-2 variants$195,625
R21 · FY2025 · NS · contact PI
Genetics-informed dissection of human brain cell-cell communication in Alzheimer's disease progression$820,536
R01 · FY2024 · AG
Investigation of active kinome networks in Alzheimer's dementia.$788,021
R01 · FY2024 · AG
Drug repositioning for Alzheimer's disease via genetics, electronic health records, and human iPSC models$779,465
R01 · FY2024 · AG
Towards a better understanding of genetic architecture of Alzheimer's disease with human iPSC models$741,571
R01 · FY2024 · AG · contact PI
Translational assessment of brain bioenergetic function in schizophrenia$704,406
R01 · FY2024 · MH
Leveraging iPSC technology to understand neuro-immune responses to SARS-CoV-2 variants$234,750
R21 · FY2024 · NS · contact PI
Drug repositioning for Alzheimer's disease via genetics, electronic health records, and human iPSC models$789,918
R01 · FY2023 · AG
Towards a better understanding of genetic architecture of Alzheimer's disease with human iPSC models$751,607
R01 · FY2023 · AG · contact PI
Translational assessment of brain bioenergetic function in schizophrenia$709,976
R01 · FY2023 · MH
Using Human iPSC Models to Determine the Mechanism of Inflammation-Induced Disruption of Dopamine Neurotransmission$195,625
R21 · FY2023 · MH · contact PI
Understanding the functional impacts of Aβ variants in Alzheimer's disease with human brain organoids$2,333,853
RF1 · FY2022 · AG · contact PI
Drug repositioning for Alzheimer's disease via genetics, electronic health records, and human iPSC models$799,966
R01 · FY2022 · AG
Towards a better understanding of genetic architecture of Alzheimer's disease with human iPSC models$758,603
R01 · FY2022 · AG · contact PI
Translational assessment of brain bioenergetic function in schizophrenia$721,836
R01 · FY2022 · MH
Chaperone-mediated Autophagy and Synaptic Dysfunction in Parkinson's Disease$494,046
R01 · FY2022 · NS
Using Human iPSC Models to Determine the Mechanism of Inflammation-Induced Disruption of Dopamine Neurotransmission$234,750
R21 · FY2022 · MH · contact PI
Drug repositioning for Alzheimer's disease via genetics, electronic health records, and human iPSC models$838,304
R01 · FY2021 · AG
Towards a better understanding of genetic architecture of Alzheimer's disease with human iPSC models$767,099
R01 · FY2021 · AG · contact PI
Translational assessment of brain bioenergetic function in schizophrenia$727,059
R01 · FY2021 · MH
Chaperone-mediated Autophagy and Synaptic Dysfunction in Parkinson's Disease$492,900
R01 · FY2021 · NS
Generation and molecular characterization of multiple human neural cell types$299,832
U19 · FY2021 · AI · contact PI
Translational assessment of brain bioenergetic function in schizophrenia$796,911
R01 · FY2020 · MH
Towards a better understanding of genetic architecture of Alzheimer's disease with human iPSC models$787,568
R01 · FY2020 · AG · contact PI
Chaperone-mediated Autophagy and Synaptic Dysfunction in Parkinson's Disease$498,683
R01 · FY2020 · NS
Towards a Better Understanding of Fragile X Syndrome Using Human Brain Organoids$429,000
R21 · FY2020 · MH · contact PI
In-line, Non-invasive, Real-time 3D Quantitative Phase Microscopy for Organoids$426,095
R21 · FY2020 · NS
Generation and molecular characterization of multiple human neural cell types$149,726
U19 · FY2020 · AI · contact PI
Chaperone-mediated Autophagy and Synaptic Dysfunction in Parkinson's Disease$520,515
R01 · FY2019 · NS
Generation and molecular characterization of multiple human neural cell types$158,626
U19 · FY2019 · AI · contact PI
Chaperone-mediated Autophagy and Synaptic Dysfunction in Parkinson's Disease$500,763
R01 · FY2018 · NS
Generation and molecular characterization of multiple human neural cell types$156,000
U19 · FY2018 · AI · contact PI
Generation and molecular characterization of multiple human neural cell types$170,539
U19 · FY2017 · AI · contact PI
High throughput multiplexed assay for chemicals affecting neuron differentiation$224,835
R43 · FY2016 · ES